CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 35 enrolled
Drug / intervention
Dexmedetomidine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03284307
NCT03284307Phase 4Completed
CompareCT.gov

UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study

University of Wisconsin, Madison·interventional·Posted Sep 15, 2017·Updated Apr 13, 2023

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine, Ketamine, and 2 other interventions for Unconsciousness and Consciousness. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUnconsciousness, Consciousness
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedSep 15, 2017
Enrollment StartAug 10, 2017
Primary CompletionMar 12, 2020
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 8.8 years ago

Interventions

Dexmedetomidinedrug

20 participants will be administered Dexmedetomidine.

Ketaminedrug

20 participants will be administered Ketamine.

Propofoldrug

20 participants will be administered Propofol.

Midazolamdrug

20 participants will be administered Midazolam.